TY - PAT
T1 - FOXM1 inhibitor compositions and methods of using the same
AU - Katzenellenbogen, John A
AU - Katzenellenbogen, Benita
AU - Kim, Sung Hoon
AU - Bindman, Noah
N1 - STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT This invention was made with government support under DK015556 awarded by the National Institutes of Health. The government has certain rights in the invention.
PY - 2025/1/7
Y1 - 2025/1/7
N2 - Provided are compounds, or pharmaceutically acceptable salts thereof, which are useful for inhibiting FOXM1, inhibiting cancer growth, and/or treating cancer. In particular, these compounds and their corresponding quaternary ammonium salts may be used to treat various forms of breast cancer.
AB - Provided are compounds, or pharmaceutically acceptable salts thereof, which are useful for inhibiting FOXM1, inhibiting cancer growth, and/or treating cancer. In particular, these compounds and their corresponding quaternary ammonium salts may be used to treat various forms of breast cancer.
M3 - Patent
M1 - 12187662
Y2 - 2019/04/09
ER -